Insights
Updating results
Showing results 1 - 24 of 40 Results per page:
No results found.
Explore our Insights
June 6, 2023
Federal Court of Appeal Clarifies Test for Inducing Infringement for Generic/Biosimilar Drugs
›January 16, 2023
Chirality Matters: Dismissal of Janssen’s Judicial Review Confirms Enantiomers Are Not “Innovative Drugs” for Obtaining Data Protection
›December 23, 2022
Patented Medicines Regulations: The Problem Is Not in Collecting the Data, but in How You Use It!
›November 16, 2022
USSC Agrees to Reconsider Amgen Inc. v Sanofi on Enablement of Antibody Genus Claims
›Subscribe to our newsletter
June 2, 2022
Federal Court sets aside Minister of Health’s approval of RUZURGI for the second time over data protection dispute
›November 19, 2021
Federal Court finds Minister of Health’s refusal of BELSOMRA CSP unreasonable, remits for redetermination
›July 9, 2021
Inducing Infringement by Product Monographs & Skill and Judgment in Medical Use Claims: Key Takeaways from the Federal Court’s decision in Hoffman-La Roche Limited v Sandoz Canada Inc.
›
Loading...
Showing results 1 - 24 of 40 Results per page:
No results found.